| 參考文獻 |
1
|
Ahn J, Schatzkin A, Lacey JV Jr, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007; 167(19):2091-2102.
|
2
|
Althuis MD, Fergenbaum JH, Garcia-Closas M, et al. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev. 2004; 13:1558-1568.
|
3
|
Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene. 2006; 25:5898-5905.
|
4
|
Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med. 2005; 143:446-457.
|
5
|
Bardia A, Hartmann LC, Vachon CM, et al. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med. 2006; 166(22):2478-2483.
|
6
|
Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst.2007; 99(2): 1695-1705.
|
7
|
Barnes-Josiah D, Potter JD, Sellers TA, et al. Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States). Cancer Causes Control. 1995; 6(2):112-118.
|
8
|
Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med. 2002; 347(12): 886-894.
|
9
|
Brekelmans CTM. Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynelo. 2003; 15:63-68.
|
10
|
Chenevix-Trench G, Spurdle A, Gatei M, et al. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002; 94:205-215.
|
11
|
Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98(24):1767-1776.
|
12
|
Cummings SR, Lee JS, Lui LY, et al. Sex hormones, risk factors and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. Cancer Epidemiol Biomarkers Prev. 2005; 14(5):1047-1051
|
13
|
Cummings SR, Tice JA, Bauer S, et al. Prevention of Breast Cancer in Postmenopausal Women: Approach to Estimating and Reducing Risk. J Natl. Inst. 2009; 101(6):384-398.
|
14
|
Cuzick J, Warwick J, Pinney E, et al. Tamoxifen and breast density in women at increased risk of breast cancer. Journal of National Cancer Insititute. 2004; 96(8):621-628.
|
15
|
Dallal CM, Sullivan-Haley J, Ross RK, et al. Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California Teachers Study. Arch Intern Med. 2007; 167(4):408-415.
|
16
|
De Geve J, Sermijn E, De Brakdleer S, et al. Hereditary breast cancer: from bench to bedside. Current Opinion in Oncology. 2008; 20:605-613.
|
17
|
Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006; 296(2):193-201.
|
18
|
Feigelson HS, Jonas CR, Teras LR, et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004; 13(2):220-224.
|
19
|
Ferrer J, Neyro JL, Estevez A. Identification of risk factors for prevention and early diagnosis of asymptomatic post-menopausal women. Maturitas. 2005; 52(Suppl 1):S7-S22.
|
20
|
Gail MH, Anderson WF, Garcia-Closas M, et al. Absolute risk models for subtypes of breast cancer. J Natl Cancer Inst 2007; 99:1657-1659.
|
21
|
Gill JK, Maskarinec G, Pagano I, et al. The association of mammographic density with ductal carcinoma in situ of the breast: the multiethnic cohort. Breast Cancer Res. 2006; 8(3): R30.
|
22
|
Greendale GA, Reboussin BA, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med. 1999; 130:262-269.
|
23
|
Harvie M, Howell A, Vierkant RA, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkdrs Prev. 2005; 193):656-661.
|
24
|
Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997; 278(17):1407-1411.
|
25
|
Hwang ES, Miglioretti DL, Ballard-Barbash R, et al. Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2007; 16(12): 2587-2593.
|
26
|
Jacobs TW, Byrne C, Colditz G, et al. Pathologic features of breast cancers in women with prior benign breast disease. Am J Clin Pathol. 2001; 115:362-369.
|
27
|
Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005; 97(10):755-765.
|
28
|
Key J, Hodgson S, Omar RZ, et al. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control. 2006; 17(6): 759-770.
|
29
|
Key T, Appleby P, Barnes I, et al. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl Cancer Inst. 2002; 94(8):606-616.
|
30
|
Lahmann PH, Schulz M, Hoffmann K, et al. Long-term weight change and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).Br J Cancer. 2005; 93(5):582-589.
|
31
|
Lahmann PH, Friedenreich C, Schuit AJ, et al. Physical activity and breast cancer risk: the European Prospective Investigation in Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2007; 16(1): 36-42.<
|
32
|
Lee SM, Park JH, Park HJ. Breast cancer risk factors in Korean women: a literature review. Int Nurs Rev. 2008; 55:355-359.
|
33
|
Marchbanks PA, Mcdonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002; 360:187-195.
|
34
|
McCormack VA, Dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risks: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006; 15(6):1159-1169.
|
35
|
Monninkhof EM, Elias SG, Vlems FA, et al. Physical activity and breast cancer: a systematic review. Epidemiology. 2007; 18(1):137-157.
|
36
|
Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women&rsquo;s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006; 295(6):629-642.
|
37
|
Radimer KL, Ballard-Barbash R, Miller JS, et al. Weight change and the risk of late-onset breast cancer in the original Framingham cohort. Nutr Cancer. 2004; 49(1): 7-13.
|
38
|
Rubinstein WS. Hereditary breast cancer in Jews. Fam Cancer. 2004; 3:249-257.
|
39
|
Thull DL, Vogel VG. Recognition and management of hereditary breast cancer syndromes.Oncologist. 2004; 9:13-24.
|
40
|
The CHEK-2-Breast Cancer Consortium. Low-penetrance susceptibility to breast cancer due to CHEK2100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31:55-59.
|
41
|
Threatt B, Norbeck JM, Ullman NS et al. Association between mammographic parenchymal pattern classification and incidence of breast cancer. Cancer. 1980; 45:2550-2556.
|
42
|
Tryggbadotti L, Tulinius H, Eyfjord JE, et al. Breast cancer risk factors and age at diagnosis: An Icelandic cohort study. Int J Cancer. 2002; 98:604-608.
|
43
|
Van den Brandt PA, Dirx MJ, Ronckers CM, et al. Height, weight, weight change and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control. 8(1):39-47.
|
44
|
Vogel VG. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer. Menopause. 2008; 15(4):782-789.
|
45
|
Vogel VG. High-risk population as targets for breast cancer prevention trials. Prev. Med. 1991; 20:86-100.
|
46
|
Vogel VG. Management of the high-risk patient. Surg Clin North Am. 2003; 83:733-751.
|
47
|
Witt I., Hansen HS, Brunner S. The risk of developing breast cancer in relation to mammography findings. Eur. J. Radiol. 1984; 4(1):65-67.
|
48
|
Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976; 37:2486-92.
|
49
|
Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol. 1976; 126:1130-1137.
|
50
|
Writing group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002; 288(3):320-333.
|
51
|
Zeleniuch-Jacquotte A, Shore RE, Koenig KL, el al. Post menopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer. 2004; 90(1):153-159.
|
52
|
Ziv E, Tice J, Smith-Bindman R, et al. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13(12):2090-2095.
|
53
|
Gierach G, Vogel V. Epidemiology of breast cancer. In: Singletary SE, Robb GL, Hortobagyi GN, eds. Advanced Therapy of Breast Disease, 2nd ed. Hamilton, Ontario, Canada: BC Decker, 2004:58-83.
|
54
|
Surveillance, Epidemiology, and End Results (SEER) Program. SEER* Stat Database:Incidence-SEER 13 Regs Limited-Use, November 2006 sub(1992-2004). Bethesda, MD:National Cancer Institute, DECCPS, Survillance Research Program, Cancer Statistics Branch. Released April 2007, based on the November 2006 submission. Available at:http://www.seer.cancer.gov. Accessed May 26, 2008.
|
55
|
Vogel VG. Epidemiology of breast cancer. In: Bland KI, Copeland EM, eds. The Breast: Comprehensive Management of Benign and Malignant Diseast, 3rd ed, vol 1.Philadelphia: WB Saunders, 2004:341-354.
|